Business Context and Reporting Period
Company: Colgate-Palmolive Company
Filing Type: Form 8-K (Current Report)
Date of Report: July 11, 2019
Event: Announcement of a Share Purchase Agreement to acquire Laboratoires Filorga Cosmétiques.
Key Financial Metrics
Transaction Value: €1,495.5 million in cash.
Additional Consideration: Interest on the purchase price calculated at an annual rate of 2% for the period from January 1, 2019, to the closing date.
Assets Acquired: The target company, including accrued cash, debt, and working capital since January 1, 2019.
Financial Statements: This filing does not provide specific revenue, profit, cash flow, margin, or debt metrics for Colgate-Palmolive or the target company.
Material Changes and Transaction Details
- Acquisition: Colgate agreed to acquire Laboratoires Filorga Cosmétiques from Filorga Initiatives.
- Closing Conditions: Subject to approval by the Austrian Federal Competition Authority, the French Competition Authority, and the Federal Antimonopoly Service of the Russian Federation.
- Termination Rights: Either party may terminate if conditions are not met by December 31, 2019, extendable to March 31, 2020.
- Risk Mitigation: The target company has obtained representation and warranty insurance for breaches of Filorga's representations.
- Post-Closing Obligations: Filorga agreed to non-compete and employee non-solicitation obligations for three years, plus transitional services.
Guidance, Outlook, and Risks
Management Commentary: The filing includes forward-looking statements regarding the expected timing of the closing and the impact on 2019 earnings. Management notes these are based on current assumptions and are not guarantees.
Risks and Contingencies:
- Regulatory approval is required from three jurisdictions; failure to obtain approval may prevent the transaction.
- Actual results may differ materially from forward-looking statements due to factors outlined in the company's 10-K and 10-Q filings.
- Colgate retains rights to recover damages for breaches of fundamental representations and warranties.
Investor Verification Checklist
- Verify the final closing date and whether the transaction was consummated.
- Confirm receipt of regulatory approvals from Austria, France, and Russia.
- Review subsequent filings for the actual impact on 2019 earnings and any changes to the purchase price due to working capital adjustments.
- Check for any material breaches of representations and warranties that may trigger insurance claims or indemnification.